Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells.

Jung WK, Heo SJ, Jeon YJ, Lee CM, Park YM, Byun HG, Choi YH, Park SG, Choi IW.

J Agric Food Chem. 2009 May 27;57(10):4439-46. doi: 10.1021/jf9003913. Epub 2009 May 1.

PMID:
19408937
2.

Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava.

Li Y, Qian ZJ, Ryu B, Lee SH, Kim MM, Kim SK.

Bioorg Med Chem. 2009 Mar 1;17(5):1963-73. doi: 10.1016/j.bmc.2009.01.031. Epub 2009 Jan 21.

PMID:
19201199
3.

Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways.

Jung WK, Ahn YW, Lee SH, Choi YH, Kim SK, Yea SS, Choi I, Park SG, Seo SK, Lee SW, Choi IW.

Food Chem Toxicol. 2009 Feb;47(2):410-7. doi: 10.1016/j.fct.2008.11.041. Epub 2008 Dec 11.

PMID:
19111593
4.

Effects of Ecklonia cava ethanolic extracts on airway hyperresponsiveness and inflammation in a murine asthma model: role of suppressor of cytokine signaling.

Kim SK, Lee DY, Jung WK, Kim JH, Choi I, Park SG, Seo SK, Lee SW, Lee CM, Yea SS, Choi YH, Choi IW.

Biomed Pharmacother. 2008 Jun;62(5):289-96. Epub 2007 Aug 10.

PMID:
17804193
5.

LUTS treatment: future treatment options.

Andersson KE.

Neurourol Urodyn. 2007 Oct;26(6 Suppl):934-47. Review.

PMID:
17696154
6.

Cross-talk between NO and arachidonic acid in inflammation.

Mariotto S, Suzuki Y, Persichini T, Colasanti M, Suzuki H, Cantoni O.

Curr Med Chem. 2007;14(18):1940-4. Review.

PMID:
17691936
7.

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P.

Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5. Epub 2006 Oct 2.

PMID:
17049716
8.

Saw palmetto for benign prostatic hyperplasia.

Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avins AL.

N Engl J Med. 2006 Feb 9;354(6):557-66.

9.

The aphrodisiac herb Tribulus terrestris does not influence the androgen production in young men.

Neychev VK, Mitev VI.

J Ethnopharmacol. 2005 Oct 3;101(1-3):319-23.

PMID:
15994038
10.

Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract.

Engström G, Henningsohn L, Steineck G, Leppert J.

BJU Int. 2005 Apr;95(6):810-5.

11.

Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid.

Palomba L, Bianchi M, Persichini T, Magnani M, Colasanti M, Cantoni O.

Free Radic Biol Med. 2004 Feb 1;36(3):319-29.

PMID:
15036351
12.

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Robertson C, Giuliano F.

Eur Urol. 2003 Dec;44(6):637-49.

PMID:
14644114
13.

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.

Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA.

BJU Int. 2003 Aug;92(3):267-70.

14.

Estimated economic costs of overactive bladder in the United States.

Hu TW, Wagner TH, Bentkover JD, LeBlanc K, Piancentini A, Stewart WF, Corey R, Zhou SZ, Hunt TL.

Urology. 2003 Jun;61(6):1123-8.

PMID:
12809878
16.

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-Committee of the International Continence Society..

Urology. 2003 Jan;61(1):37-49. Review. No abstract available.

PMID:
12559262
17.

Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component.

Anglin IE, Glassman DT, Kyprianou N.

Prostate Cancer Prostatic Dis. 2002;5(2):88-95. Review.

18.

Aphrodisiac properties of Tribulus Terrestris extract (Protodioscin) in normal and castrated rats.

Gauthaman K, Adaikan PG, Prasad RN.

Life Sci. 2002 Aug 9;71(12):1385-96.

PMID:
12127159
19.

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela-Navarrete R, Raynaud JP.

Eur Urol. 2002 May;41(5):497-506; discussion 506-7.

PMID:
12074791
20.

Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia.

Dinh DT, Frauman AG, Sourial M, Casley DJ, Johnston CI, Fabiani ME.

Endocrinology. 2001 Mar;142(3):1349-56.

PMID:
11181554

Supplemental Content

Support Center